Skip to main content
PDEX
NASDAQ Life Sciences

Pro-Dex Q4 Revenue Beats Estimates on Orthopedic Handpiece Sales

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$65
Mkt Cap
$197.153M
52W Low
$23.47
52W High
$69.855
52W Position info
177% above low
Off High info
7.0% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PDEX has more than doubled off its 52-week low of $23.47.

Summary

Pro-Dex reported fiscal Q4 revenue of $20.41 million, beating the single-analyst consensus of $19.20 million and up 17% year-over-year. Gross margin more than doubled to 35% from 20%, driven by favorable product mix and contribution from the APM subsidiary. Net income was $2.9 million, or $0.87 per diluted share. The company did not provide specific guidance for the upcoming quarter or fiscal year. This follows the 8-K filed on August 28 disclosing performance bonuses for the CEO and CFO, and the activist investor group holding over 31% of shares. The stock trades at 23 times forward earnings, with a median price target of $70.

Updates

  1. · Dow Jones Newswires — Shares surged 15% to $71.07 midday Friday. The customer had held the next-gen handpiece for most of the quarter, releasing it late in the period, allowing Pro-Dex to restart production and shipments.

At the time of this announcement, PDEX was trading at $65.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $197.2M. The 52-week trading range was $23.47 to $69.86. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PDEX - Latest Insights

PDEX
Oct 29, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $61.60
Real-time Price: $62.00 info
Change: +$0.400 (+0.65%) info
Market Cap: $198.4M info
PDEX
Oct 29, 2026, 4:00 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $61.25
Real-time Price: $62.00 info
Change: +$0.750 (+1%) info
Market Cap: $198.4M info
PDEX
Sep 03, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $62.00 info
Change: -$3.00 (-5%) info
Market Cap: $198.4M info
PDEX
Sep 03, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $62.00 info
Change: -$3.00 (-5%) info
Market Cap: $198.4M info
PDEX
Jun 26, 2026, 5:59 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $61.47
Real-time Price: $62.00 info
Change: +$0.530 (+0.86%) info
Market Cap: $198.4M info